logo

DLB

Dolby Laboratories·NYSE
--
--(--)
--
--(--)
3.69 / 10
Netural

DLB's fundamentals are under pressure: revenue fell 3% YoY to $346.7M and net income dropped 21% to $53.3M, hampered by restructuring and macro headwinds. Key positives include an Asset-MV score of 2 and ROE (diluted) of 2, but the stock also shows weaknesses in Revenue-MV (1) and PB-ROE (0). The mixed factor scores translate to a neutral fundamental rating, indicating limited upside without clear catalysts.

Fundamental(3.69)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.78
Score1/3
Weight13.77%
1M Return10.73%
Annualized return on equity (%)
Value10.00
Score3/3
Weight10.26%
1M Return8.87%
Profit-MV
Value-0.83
Score3/3
Weight17.97%
1M Return12.99%
PB-ROE
Value0.89
Score0/3
Weight7.30%
1M Return6.59%
Net profit margin (%)
Value19.01
Score2/3
Weight4.49%
1M Return4.16%
Net cash flow from operating activities / Total liabilities (%)
Value0.79
Score2/3
Weight6.26%
1M Return5.94%
ROE (diluted) (%)
Value9.72
Score2/3
Weight3.69%
1M Return3.58%
Asset-MV
Value-0.50
Score2/3
Weight21.50%
1M Return15.32%
ROE (%)
Value10.00
Score3/3
Weight10.26%
1M Return8.87%
Net profit / Total operating revenue (%)
Value19.01
Score2/3
Weight4.49%
1M Return4.16%
Is DLB fundamentally strong?
  • DLB scores 3.69/10 on fundamentals and holds a Fair valuation at present. Backed by its 2.04% ROE, 18.08% net margin, 25.76 P/E ratio, 2.38 P/B ratio, and -8.73% earnings growth, these metrics solidify its Netural investment rating.